Digirad Corporation (DRAD)
Symbol Info
Listed Symbol DRAD
Name Digirad Corporation
Share Info
Annual Info
Latest Fiscal Dividend Per Share $1.65
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $104,180,000
Latest Fiscal EPS $0.33
Price Info
21 Day Moving Average $4.4948
21 Day EMA $4.464580
50 Day Moving Average $4.5877
50 Day EMA $4.725620
200 Day EMA $6.900580
200 Day Moving Average 6.394000
52 Week High $13.81
52 Week Low $3.97
52 Week Change $-67.686600
Alpha -0.037804
Beta 2.2974
Standard Deviation 0.156616
R2 0.253774
Periods 60
Share Information
10 Day Average Volume 32,401
20 Day Average Volume 25,435
30 Day Average Volume 105,498
50 Day Average Volume 64,951
Outstanding Shares 2,042,493
Float Shares 800,807
Percent Float 39.21%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 68
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 39,334
Institute Holdings Percent 43.200000
Institute Sold Previous 3 Months 111,694
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months 11
Insider Holdings Percent 60.80%
Insider Sold Previous 3 Months -
Insiders Shares Owned 1,241,686
Price Change
7 Day Price Change $0.2900000
7 Day Percent Change 7.18%
21 Day Price Change $-0.4500003
21 Day Percent Change -9.41%
30 Day Price Change $-0.6800003
30 Day Percent Change -13.57%
Month To Date Price Change $-0.15
Month To Date Percent -3.35%
90 Day Price Change $-1.2
90 Day Percent Change -21.70%
Quarter To Date $-0.15
Quarter To Date Percent -3.35%
180 Day Price Change $-2.748
180 Day Percent Change -38.82%
200 Day Price Change $-4.361
200 Day Percent Change -50.18%
Year To Date $-1.37
Year To Date Percent -24.04%
Profile
Description Digirad Corp is a United States-based company which delivers healthcare solutions. The diverse portfolio of healthcare solutions of the company includes mobile healthcare solutions and medical equipment and services, including diagnostic imaging and patient monitoring. The company provides hospitals, physician practices, and imaging centers throughout the United States access to technology and services necessary to provide exceptional patient care in the rapidly changing healthcare environment. The company operates through three reportable segments namely Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging. It generates a majority of its revenue from the Diagnostic Services followed by Mobile Healthcare segment.
Details
Issue Type CS
Market Cap $8,843,995
Sec Type EQS
Auditor BDO USA, LLP
Total Shares Outstanding 2,042,493
CEO Matthew G. Molchan
Employees 452
Last Audit UE
Classification
CIK 0000707388
Industry Medical Devices
Sector Healthcare
NAICS Electromedical and Electrotherapeutic Apparatus Manufacturing(334510)
Info
Address 1048 Industrial Court
Suite E
Suwanee, GA 30024
Website https://www.digirad.com
Facisimile +1 858 726-1700
Telephone +1 858 726-1600
Email info@digirad.com
Key Ratios
Profitability
EBIT Margin -4.5
EBITDA Margin 3.8
Pre-Tax Profit Margin -0.4
Profit Margin Cont -5.35
Gross Margin 16.90
Profit Margin TOT -5.9
Income Statements
Revenue $75,638,000
Revenue Per Share $37.0322
Revenue 3 Years $-8.91
Revenue 5 Years $13.62
Valuation Measures
PE Ratio -
Enterprise Value $27,684,368
Price To Sales 0.116925
Price To Free Cash -3.1
PE High Last 5 Years -
Price To Book 0.4
Price To Cash Flow 3.5
PE Low Last 5 Years -
Price To Tangible Book 0.5
Financial Strength
Total Debt To Equity 0.8
Int Coverage -5.9
Current Ratio 1.4
Leverage Ratio 2.3
Quick Ratio 0.9
Long Term Debt To Capital 0.44
Assets
Receivables Turnover 2.2
Invoice Turnover 13.20
Assets Turnover 0.50
Management Effectiveness
Return Assets -10.17
Return On Equity -22.27
Return On Capital -13.66
Dividends
Dividend 3 Years $-21.9
Dividend 5 Years $-9.23
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type Cash


Your Recent History
NASDAQ
DRAD
Digirad
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.